Vaxdyn
Vaxdyn develops multi-valent vaccines designed to prevent infections caused by antibiotic-resistant bacteria. The company utilizes its AcinetoVax technological platform to create inactivated, endotoxin-free whole-cell vaccines targeting pathogens such as Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae. These products are intended for global populations at risk of infections in the post-antibiotic era.
Visit websiteDos Hermanas, Spain
Biotechnology
Pharmaceuticals
Healthcare
Funding summary
- Total raised
- €14.5M
- Funding rounds
- 1
Investors in Vaxdyn
Investors on record for Vaxdyn. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Vaxdyn?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors